# Combined Antihypertensive Therapy and Sexual Dysfunction

> **NCT01238705** · PHASE4 · UNKNOWN · sponsor: **LanZhou University** · enrollment: 280 (estimated)

## Conditions studied

- Hypertension
- Sexual Dysfunction

## Interventions

- **DRUG:** Felodipine add Irbesartan
- **DRUG:** Felodipine add Metoprolol

## Key facts

- **NCT ID:** NCT01238705
- **Lead sponsor:** LanZhou University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-04
- **Primary completion:** 2010-10
- **Final completion:** 2010-11
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2010-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01238705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01238705, "Combined Antihypertensive Therapy and Sexual Dysfunction". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01238705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*